Clinical Trials Browser

Phase 1/2 × INDUSTRY × avapritinib × Clear all

NCT04773782 2026-01-13

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Phase 1/2 Completed

Glioma, Recurrence, Central Nervous System Neoplasms

NCT04254939 2023-04-27

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

Phase 1/2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors